Page last updated: 2024-09-03

2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid and phenobarbital

2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid has been researched along with phenobarbital in 1 studies

Compound Research Comparison

Studies
(2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid)
Trials
(2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid)
Recent Studies (post-2010)
(2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid)
Studies
(phenobarbital)
Trials
(phenobarbital)
Recent Studies (post-2010) (phenobarbital)
1110918,3366191,117

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanimura, A; Turner, RJ1

Other Studies

1 other study(ies) available for 2-(2-(5-carboxy)oxazole)-5-hydroxy-6-aminobenzofuran-n,n,o-triacetic acid and phenobarbital

ArticleYear
Calcium release in HSY cells conforms to a steady-state mechanism involving regulation of the inositol 1,4,5-trisphosphate receptor Ca2+ channel by luminal [Ca2+].
    The Journal of cell biology, 1996, Volume: 132, Issue:4

    Topics: Calcium; Calcium Channels; Cell Line; Fluorescent Dyes; Fura-2; Humans; Hypnotics and Sedatives; Inositol 1,4,5-Trisphosphate Receptors; Ion Channel Gating; Phenobarbital; Receptors, Cytoplasmic and Nuclear

1996